ACTIVE_NOT_RECRUITING

Metastatic Tumor Research and Outcomes Network

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).

Official Title

Metastatic Tumor Research and Outcome Network A Multicenter Prospective Registry for the Management and Outcome of Metastatic Spine Tumors

Quick Facts

Study Start:2017-11-15
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT02830451

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patient 18 or older.
  2. * Patient diagnosed with a metastatic tumor of the spine
  3. * Informed consent obtained, i.e.:
  4. * Ability to understand the content of the patient information/ICF
  5. * Willingness and ability to participate in the registry according to the Registry Plan
  6. * Signed and dated EC/IRB approved written informed consent (if consent is required by the EC/ IRB at the registry site)
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Charles G. Fisher, MD
PRINCIPAL_INVESTIGATOR
Vancouver General Hospital and the University of British Columbia

Study Locations (Sites)

University of California The UCSF Spine Center Department of Neurological Surgery
San Francisco, California, 94143
United States
Rush University Medical Center University Neurosurgery
Chicago, Illinois, 60612
United States
Johns Hopkins University Department of Neurosurgery / Spine Division
Baltimore, Maryland, 21205
United States
Harvard Medical School Department of Neurosurgery
Boston, Massachusetts, 02114
United States
Mayo Clinic Department of Neurosurgery
Rochester, Minnesota, 55905
United States
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065
United States
University of Rochester School of Medicine and Dentistry Department of Orthopaedic Surgery and Neurosurgery
Rochester, New York, 14642
United States
Westchester Medical Center Department of Neurosurgery
Valhalla, New York, 10595
United States
Penn Presbyterian Medical Center Department of Neurosurgery
Philadelphia, Pennsylvania, 19104
United States
The Warren Alpert Medical School of Brown university Department of Neurosurgery
Providence, Rhode Island, 02903
United States
The University of Texas MD Anderson Cancer Center Department of Neurosurgery
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: AO Innovation Translation Center

  • Charles G. Fisher, MD, PRINCIPAL_INVESTIGATOR, Vancouver General Hospital and the University of British Columbia

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-11-15
Study Completion Date2025-12

Study Record Updates

Study Start Date2017-11-15
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • Registry
  • Spine
  • Surgery
  • Medical Oncology
  • Radiation Oncology
  • Neoplasms
  • Metastasis
  • Chemotherapy
  • Radiation Therapy
  • Tumor Markers

Additional Relevant MeSH Terms

  • Metastatic Spine Tumor